EyeGate Pharma Reports Second Quarter 2019 Financial Results and Provides Business Update
WALTHAM, MA, August 8, 2019 – EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, today announced financial results for the quarter ended June 30, 2019 and provided an update on recent corporate and operational activities. Stephen From, Chief Executive Officer of…